An RSV vaccine cut hospital stays in older adults, with most to gain for weak immunity
In an analysis of the Danish DAN-RSV trial, published in The Lancet Healthy Longevity in October 2026, RSV hospitalization was more than nine-fold higher in unvaccinated older adults with weakened immunity, and…
